NO301844B1 - DNA-molekyl som koder for en polypeptidanalog til S1-underenheten i Bordetella-eksotoksin, og fremgangsmåte for fremstilling av en proteinanalog til S1-underenheten i Bordetella-eksotoksin - Google Patents

DNA-molekyl som koder for en polypeptidanalog til S1-underenheten i Bordetella-eksotoksin, og fremgangsmåte for fremstilling av en proteinanalog til S1-underenheten i Bordetella-eksotoksin Download PDF

Info

Publication number
NO301844B1
NO301844B1 NO891842A NO891842A NO301844B1 NO 301844 B1 NO301844 B1 NO 301844B1 NO 891842 A NO891842 A NO 891842A NO 891842 A NO891842 A NO 891842A NO 301844 B1 NO301844 B1 NO 301844B1
Authority
NO
Norway
Prior art keywords
subunit
recombinant
protein
toxin
subunits
Prior art date
Application number
NO891842A
Other languages
English (en)
Norwegian (no)
Other versions
NO891842L (no
NO891842D0 (no
Inventor
Iii Walter Neal Burnette
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26788722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO301844(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO891842D0 publication Critical patent/NO891842D0/no
Publication of NO891842L publication Critical patent/NO891842L/no
Publication of NO301844B1 publication Critical patent/NO301844B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO891842A 1987-09-04 1989-05-03 DNA-molekyl som koder for en polypeptidanalog til S1-underenheten i Bordetella-eksotoksin, og fremgangsmåte for fremstilling av en proteinanalog til S1-underenheten i Bordetella-eksotoksin NO301844B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9430787A 1987-09-04 1987-09-04
US23248288A 1988-08-17 1988-08-17
PCT/US1988/002983 WO1989001976A1 (en) 1987-09-04 1988-08-26 Recombinant dna-derived bordetella toxin subunit analogs

Publications (3)

Publication Number Publication Date
NO891842D0 NO891842D0 (no) 1989-05-03
NO891842L NO891842L (no) 1989-06-21
NO301844B1 true NO301844B1 (no) 1997-12-15

Family

ID=26788722

Family Applications (2)

Application Number Title Priority Date Filing Date
NO891842A NO301844B1 (no) 1987-09-04 1989-05-03 DNA-molekyl som koder for en polypeptidanalog til S1-underenheten i Bordetella-eksotoksin, og fremgangsmåte for fremstilling av en proteinanalog til S1-underenheten i Bordetella-eksotoksin
NO19972642A NO325016B1 (no) 1987-09-04 1997-06-09 Fremgangsmate for fremstilling av en proteinanalog til Bordetella-eksotoksin, polypeptidanalog av S1-subenhet fra Bordetella pertussis-toksin og vaksine mot pertussis.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO19972642A NO325016B1 (no) 1987-09-04 1997-06-09 Fremgangsmate for fremstilling av en proteinanalog til Bordetella-eksotoksin, polypeptidanalog av S1-subenhet fra Bordetella pertussis-toksin og vaksine mot pertussis.

Country Status (16)

Country Link
US (1) US5773600A (de)
EP (2) EP0629696A1 (de)
JP (1) JP2918895B2 (de)
KR (1) KR0168039B1 (de)
CN (1) CN1033866C (de)
AT (1) ATE125568T1 (de)
CA (1) CA1341560C (de)
DE (1) DE3854213T3 (de)
DK (1) DK175821B1 (de)
ES (1) ES2076160T5 (de)
FI (1) FI101632B (de)
GR (1) GR3017497T3 (de)
IE (1) IE69753B1 (de)
IL (3) IL103121A (de)
NO (2) NO301844B1 (de)
WO (1) WO1989001976A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223334B (it) * 1987-11-02 1990-09-19 Sclavo Spa Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
US5925546A (en) * 1987-11-02 1999-07-20 Chiron S.P.A. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
US6713072B1 (en) * 1987-11-02 2004-03-30 Chiron S.R.L. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
US5332583A (en) * 1987-11-24 1994-07-26 Connaught Laboratories Limited Vaccine containing genetically-detoxified pertussis holotoxin
US5358868A (en) * 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
US7232671B2 (en) * 1989-02-15 2007-06-19 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
CA2009991A1 (en) * 1989-02-15 1990-08-15 Witold Cieplak Pertussis toxin gene: cloning and expression of protective antigen
ES2078258T3 (es) * 1989-04-28 1995-12-16 Sclavo Spa Mutantes de toxina pertussica, cepas de bordetella capaces de producir tales mutantes y su uso en el desarrollo de vacunas antipertussicas.
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
US20030072774A1 (en) * 1994-06-10 2003-04-17 Diane M. Gajewczyk Proteinaceous adjuvants
PT826001E (pt) * 1995-05-04 2002-12-31 Aventis Pasteur Vacinas acelulares contra a tosse convulsa e metodos para a sua preparacao
CA2253937A1 (en) * 1996-05-10 1997-11-20 Phylomed Corporation Methods for oxidizing disulfide bonds using ozone
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
US6818222B1 (en) 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
CN101031655A (zh) 2004-07-26 2007-09-05 陶氏环球技术公司 通过株工程改进蛋白表达的方法
CN101203605B (zh) * 2004-12-17 2016-01-27 由卫生福利和体育大臣代表的荷兰王国 革兰氏阴性菌的lps的脱酰基化
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
WO2011126811A2 (en) 2010-03-30 2011-10-13 Pfenex Inc. High level expression of recombinant toxin proteins
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
SG11201500573RA (en) 2012-08-06 2015-02-27 Glaxosmithkline Biolog Sa Method for eliciting in infants an immune response against rsv and b. pertussis
BR112015021523A8 (pt) 2013-03-08 2021-06-29 Crucell Holland Bv composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
SG11201600709TA (en) 2013-08-05 2016-02-26 Glaxosmithkline Biolog Sa Combination immunogenic compositions
CN109172818B (zh) * 2018-08-02 2021-10-22 浙江康佰裕生物科技有限公司 一种蛋白牛痘疫苗及其效力检测方法
CN113226361A (zh) * 2018-10-15 2021-08-06 代表亚利桑那大学的亚利桑那校董会 疫苗多肽组合物及方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704362A (en) * 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
CA1340373C (en) * 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
EP0275689B1 (de) * 1986-12-23 1992-09-02 The Board Of Trustees Of The Leland Stanford Junior University Modifiziertes Pertussistoxin
IT1223334B (it) * 1987-11-02 1990-09-19 Sclavo Spa Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
IT1223529B (it) * 1987-12-18 1990-09-19 Sclavo Spa Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse

Also Published As

Publication number Publication date
FI101632B1 (fi) 1998-07-31
EP0306318A1 (de) 1989-03-08
FI101632B (fi) 1998-07-31
US5773600A (en) 1998-06-30
IE69753B1 (en) 1996-10-02
ATE125568T1 (de) 1995-08-15
ES2076160T5 (es) 2004-12-01
GR3017497T3 (en) 1995-12-31
DE3854213D1 (de) 1995-08-31
EP0306318B1 (de) 1995-07-26
DK216289D0 (da) 1989-05-03
IE882668L (en) 1989-03-04
EP0306318B2 (de) 2004-04-28
WO1989001976A1 (en) 1989-03-09
CA1341560C (en) 2007-10-30
NO891842L (no) 1989-06-21
FI892131L (fi) 1989-05-03
KR0168039B1 (ko) 1999-01-15
JP2918895B2 (ja) 1999-07-12
KR890701758A (ko) 1989-12-21
JPH04501051A (ja) 1992-02-27
NO972642L (no) 1997-07-28
EP0629696A1 (de) 1994-12-21
ES2076160T3 (es) 1995-11-01
DE3854213T3 (de) 2004-10-21
NO325016B1 (no) 2008-01-14
NO891842D0 (no) 1989-05-03
CN1033072A (zh) 1989-05-24
AU623867B2 (en) 1992-05-28
IL103121A (en) 1995-08-31
DE3854213T2 (de) 1995-12-07
NO972642D0 (no) 1997-06-09
FI892131A0 (fi) 1989-05-03
DK216289A (da) 1989-06-30
DK175821B1 (da) 2005-03-14
IL103121A0 (en) 1993-02-21
AU2386488A (en) 1989-03-31
CN1033866C (zh) 1997-01-22
IL87608A0 (en) 1989-01-31

Similar Documents

Publication Publication Date Title
EP0306318B2 (de) Analoge der Untereinheit des von rekombinanter DNS abgeleiteten Bordetella-Toxins
JP3242106B2 (ja) 組換えｄｎａ由来コレラトキシンサブユニット類似体
EP0712442B1 (de) Rekombinante tetc-fusionsprotein enthaltene impfstoffzusammensetzungen
Burnette et al. Direct expression of Bordetelia pertussis toxin subunits to high levels in Escherichia coli
Loosmore et al. Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine
AU644829B2 (en) Recombinant vaccine for porcine pleuropneumonia
AU633842B2 (en) Recombinant systems for expression of cholera b-subunit with the aid of foreign promoters and/or leader peptides
US6309648B1 (en) Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections
KR100217809B1 (ko) 재조합 bcg 백신
US7144576B1 (en) Modified pertussis toxin
AU623867C (en) Recombinant DNA-derived bordetella toxin subunit analogs
EP0502016B1 (de) Neuer impfstoff
US20060159710A1 (en) Pertussis toxin gene:cloning and expression of protective antigen
EP0742829B1 (de) Expression heterologer proteine in abgeschwächten bakterien mittels des htra-promotors
US20030044430A1 (en) Pertussis toxin gene: cloning and expression of protective antigen
US20030044891A1 (en) Pertussis toxin gene: cloning and expression of protective antigen
Burnette et al. Progress with a recombinant whooping cough vaccine: a review
WO1992017587A1 (en) Bordetella bronchiseptica outer membrane antigen

Legal Events

Date Code Title Description
MK1K Patent expired